1973
DOI: 10.1172/jci107505
|View full text |Cite
|
Sign up to set email alerts
|

B Lymphocytes in Untreated Patients with Malignant Lymphoma and Hodgkin's Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
8
1
1

Year Published

1975
1975
1984
1984

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 64 publications
(13 citation statements)
references
References 36 publications
3
8
1
1
Order By: Relevance
“…1976 The finding that peripheral blood lymphocytes from patients with untreated Hodgkin's disease react normally when used as a source of responder cells in the MLR test (Fig. 4) is consistent with other reports in the literature (44,45). After total lymphoid irradiation, there was a marked reduction of the ability of the peripheral blood lymphocytes to respond in the MLR reaction (Fig.…”
Section: Reversal Of Cell Surface Abnormalities Of T Lymphocytes Insupporting
confidence: 87%
“…1976 The finding that peripheral blood lymphocytes from patients with untreated Hodgkin's disease react normally when used as a source of responder cells in the MLR test (Fig. 4) is consistent with other reports in the literature (44,45). After total lymphoid irradiation, there was a marked reduction of the ability of the peripheral blood lymphocytes to respond in the MLR reaction (Fig.…”
Section: Reversal Of Cell Surface Abnormalities Of T Lymphocytes Insupporting
confidence: 87%
“…Our normal values obtained by the examination of B and T cell mar kers from PB are about the same as or somewhat lower than those gener ally mentioned in the literature [3,4,9,15,16,20,22,27], Relatively fewer data are available about B and T cell markers from BM [1,5,14,17,19,20,23,25]. It has been firmly established that mature T lympho cytes do exist within the BM, too.…”
Section: Discussionsupporting
confidence: 61%
“…It has long been known that a few aty pical lymphocytes may be present in the peripheral blood (PB) of patients with non-leukemic non-Hodgkin lymphomas (NHL) [1], especially in cases with bone marrow involvement and certain histo pathologic types [2][3][4].…”
Section: Introductionmentioning
confidence: 99%